 |
 |

The Hypocholesterolemic Effects of β-Glucan
Stephen Warshafsky, MD
New York Medical College Valhalla
JAMA. 1991;266(8):1079-1080.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
To the Editor.
—The recent article by Davidson et al1 claims a power of 0.90 with an of.05 to detect a 0.39-mmol/L (15-mg/dL) change in total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels between the control and experimental groups. In my estimation, their experimental groups of 20 to 23 subjects each and placebo group of 15 are not sufficient to achieve such a power.
As serum cholesterol levels are considered a continuous variable, an estimate for population size for each experimental and placebo group can be calculated by using the Student t test to compare means between placebo and each experimental group, using the following formula: N = ([1/q1 + 1/q2]S2[z + zβ]2)/E2, where N = total number of subjects required, S=SD from the mean, E = effect size, z = the standard normal deviate for (z = 1.96 when =.05), z
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|